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Arsenic (As), a ubiquitous element in nature
(Cullen and Reimer 1989), has been identiﬁed
as a human carcinogen by the International
Agency for Research on Cancer (IARC 1987).
Chronic exposure to drinking water containing
high levels of inorganic arsenic (iAs) is associ-
ated with manifestations of various skin dis-
eases (Tondel et al. 1999), diabetes (Bates et al.
1992; Tseng et al. 2000), cardiovascular dis-
ease (Engel et al. 1994), and cancers of several
organs (Bates et al. 1992; Chen et al. 2005). 
Recent development of analytical methods
for As speciation has resulted in a large number
of publications on As metabolism in humans.
Until now, two important theories concerning
As biotransformation attracted much attention
of researchers in this ﬁeld. One theory is that
the classic metabolic pathway of As in mam-
mals consists mainly of two reduction steps
and two methylation steps as follows: iAsV →
iAsIII → monomethylarsonic acid (MMAV) →
MMAIII → dimethylarsinic acid (DMAV)
(Aposhian et al. 2004). The other theory is
that the new As pathway is based on the forma-
tion of As–glutathione complexes (Hayakawa
et al. 2005). These complexes cannot be
detected in human urine because they are
degraded by γ-glutamyltransferase (GGT) in
the microvilli of the proximal tubules in the
kidney. The products of the degradation may
be transformed into iAs, MMA, or DMA
(Kala et al. 2004). However, both theories sug-
gest the two methylation steps are involved in
the metabolism of As. If these theories are
correct, then methylation is key to understand-
ing the biotransformation of As. In addition,
trivalent forms of As are more toxic than the
pentavalent forms of As, with MMAIII being
the most toxic As metabolite (Bing et al. 2001;
Nesnow et al. 2002; Styblo et al. 2000).
Cytotoxicity assays revealed the following
order of toxicity of the arsenicals: MMAIII >
iAsIII > iAsV > MMAV = DMAV (Petrick et al.
2000). Consequently, the traditional belief
that biomethylation was a detoxiﬁcation path-
way of iAs has been questioned (Kurttio et al.
1998; Styblo et al. 2002). The new under-
standing of As metabolism creates interesting
challenges in evaluating health effects of in
populations exposed to iAs because of large
variations in the factors that affect metabolism,
such as nutrition (Gamble et al. 2005), genet-
ics (Chung et al. 2002), sex (Shraim et al.
2003; Tseng et al. 2005), and age (Chowdhury
2003; Tseng et al. 2005). 
Exposure to As in drinking water at con-
centrations as low as 50 µg/L has been shown
to adversely affect children’s intellectual func-
tion in Bangladesh (Wasserman et al. 2004),
but little is known about the potential differ-
ences, such as concentrations or distribution
of urinary As metabolites in children and
adults. Here, we report the results of a cross-
sectional study we conducted in Inner
Mongolia, China, on the concentrations and
the distribution of urinary As metabolites
(iAs, MMA, and DMA) in children and
adults exposed to 20, 90, or 160 µg/L As in
groundwater used for drinking. In addition,
comparing urinary As concentrations and the
distribution of As species, we also apply two
indices, the primary methylation index [PMI =
(MMA + DMA)/total As (TAs)] and the sec-
ondary methylation index [SMI = DMA/
(MMA + DMA)], to evaluate As methylation
ability. PMI calculated as MMA/iAs and SMI
calculated as DMA/MMA were previously
developed for As methylation ability (Chen
et al. 2003a, 2003b; Tseng et al. 2005). Our
new methods for calculating PMI and SMI are
more logical. According to the pathway of As
metabolism, secondary methylation can only
proceed on the basis of primary methylation;
consequently, parts of the As products result-
ing from primary methylation are further
methylated. Therefore, to evaluate the primary
methylation ability, not only the primary but
also the secondary methylation products
should be considered. PMI and SMI show dif-
ferences in As metabolism between children
and adults but not between males and females.
Finally, we report results of urinary As metabo-
lites in 11 pairs of children and their mothers
to illustrate the possible role of genetics in
As metabolism. 
Methods
Study population. We recruited 233 subjects
from three villages—Tianjiaying, Koukenban,
and Naimoban near Hohhot, Inner Mongolia,
China. The control group with 36 individuals
(mean age, 22.6 years) resided in Tianjiaying
village on the outskirts of Hohhot, where the
deep tube-well water with an iAs concentra-
tion of 20 µg/L was provided by centralized
waterworks. Currently, the drinking water
standard in China for iAs is 50 µg/L
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BACKGROUND: We report the concentrations and distributions of urinary arsenic (As) metabolites in
233 residents exposed to 20, 90, or 160 µg/L inorganic arsenic (iAs) in drinking water from three vil-
lages in Hohhot, Inner Mongolia, China, that formed one control and two exposed groups. 
METHODS: We used hydride generation-atomic absorption spectrometry (HGAAS) to determine
iAs, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA). 
RESULTS: The concentrations of each urinary As species in the two exposed groups were signiﬁcantly
higher than in the control group for both children and adults. Both children and adults in exposed
groups had higher percent iAs and MMA and lower percent DMA, and low primary and secondary
methylation indices (PMI and SMI, respectively) than those in the control group. However, children
showed signiﬁcant increases in percent DMA and the SMI as well as decreases in the percent MMA
when the iAs exposure level increased from 90 to 160 µg/L. In addition, children in the two exposed
groups showed lower percent MMA but higher percent DMA and higher SMI than adults in the
same exposed group. No signiﬁcant differences in As metabolite concentrations and distributions were
found between males and females in each group. A signiﬁcant correlation was also found in the SMI
between 11 pairs of children and their mothers from the 160-µg/L–exposed group. 
CONCLUSIONS: Children had higher a capacity for secondary methylation of As than adults when
exposed to the same concentrations of iAs in drinking water. Exposure to As may increase the
capacity for methylation in children to some extent. 
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villages, a centralized tap water system was
established in 1998 to eliminate ﬂuoride from
tube well water. Unfortunately, the new tap
water system contained concentrations of iAs
exceeding 50 µg/L and concentrations in
Naimoban and Koukenban were 90 and 160
µg/L, respectively. The number of villagers
participating in this study was 97 from
Naimoban (mean age, 26.8 years) and 100
from Koukenban (mean age, 25.4 years). In
addition, we also recruited 11 pairs of chil-
dren (age range, 2–5 years) and their mothers
(age range, 25–31 years) from Koukenban. 
We have complied with the Declaration
of Helsinki Ethical Principles for Medical
Research Involving Human Subjects (World
Medical Association (World Medical
Association 1989). All 233 recruited villagers
gave informed consent before participating.
Data on health status, cigarette smoking,
dietary habits, history of chronic disease, fam-
ily members, place of birth, race, education,
economic conditions, and reproductive con-
ditions were obtained by questionnaire. The
distribution of age was similar for males and
females in each group. Trained medical doc-
tors conducted detailed physical examinations
according to the Diagnosis Standards on
Arsenicosis of China (WS/T211-2001;
Ministry of Health 2001) to identify cases of
arsenicosis. Previously, there had been no cases
of arsenicosis identiﬁed in the villages in this
study. The subjects were generally healthy and
had no history of other chronic diseases. 
Sample collection. Water samples were col-
lected from the delivery ports of the deep wells
and the waterworks and stored in 15-mL
polypropylene conic tubes (Becton Dickinson
Labware, Franklin Lakes, NJ, USA) without
acidification and kept on ice. Our previous
studies have demonstrated that iAs in water
samples without acidification from these vil-
lages was stable when stored at 4°C within
1 month of sampling (unpublished data).
Sampling took place three times in three differ-
ent seasons. Samples of first-morning void
urine (5 mL) were obtained in 15-mL
polypropylene tubes (Sarstedt, Tokyo, Japan)
and kept on ice. Within 8 hr, the urine sam-
ples were taken to the Centre of Disease
Control in Hohhot and stored frozen at –20°C
for 5 days. Typically, a dozen urine samples
and water samples, kept on dry ice, were sent
to the Laboratory of Arsenic Analysis in China
Medical University (Shenyang, Liaoning
province, China). Water samples were analyzed
upon arrival; urine samples were stored at
–80°C and analyzed within 3 months.
Reagents and standards. Arsenate
(Na3AsO4 • 12H2O), arsenite (NaAsO2), HCl,
NaOH, and NaBH4 were purchased from the
Shanghai Chemical Co. (Shanghai, China). All
reagents used in this study are analytical grade
(the highest grade commercially available in
China) and As free (< 0.01 mg/L). We used a
mixed As standard of 1,000 mg/L MMA,
DMA, and trimethylarsonic acid (TMA) (Tri
Chemical Laboratories Inc., Yamanashi,
Japan). We acquired an iAs standard of 1,000
mg/L from the National Center for Standard
Reference Materials (Beijing, China). Standard
reference material of freeze-dried urine (SRM
2670) for toxic metals was obtained from the
U.S. National Institute of Standards and
Technology (NIST; Gaithersburg, MD, USA). 
Determination of As metabolites. We
determined As species (iAs, MMA, DMA, and
TMA) in urine using atomic absorption spec-
trophotometer (AA-6800) with an As specia-
tion pretreatment system (ASA-2SP; Shimadzu
Co., Kyoto, Japan). Speciation analysis was
based on the well-established hydride genera-
tion of volatile arsines, followed by cryogenic
separation in liquid nitrogen. The limit of
detection of 1 ng ± < 5% for each of the four
As species was determined using hydride gen-
eration-atomic absorption spectrometry
(HGAAS). Brieﬂy, 1 mL urine that had been
stored at –80°C was thawed at room tempera-
ture and digested with 2 N–NaOH solutions
at 100°C for 3 hr in a 15-mL polymethylpen-
tene test tube (Sarstedt), followed by dilution
with Milli-Q water (Millipore, Yonezawa,
Japan). This digestion procedure did not alter
the distribution of iAs or methylated arsenicals
(Yamauchi and Yamamura. 1984). The
absorbance of As in the digested urine samples
was determined at 193.7 nm. Quality control
for As determinations included the analysis of
SRM2670. The NIST-certiﬁed concentration
values for As were 480 ± 100 µg/L. The values
measured in our laboratory were 474 ± 20
µg/L. The reliability of As species separation
was evaluated by the analytical recoveries of
added As species. Spiking urine samples with
10 µg/L of iAs, MMA, DMA, and TMA
resulted in recoveries of 81–92%, 88–98%,
89–103%, and 80–95% for iAs, MMA,
DMA, and TMA, respectively. Because no
TMA was detected in the urine samples of any
subject, we report the TAs concentrations by
summing the concentrations of iAs, MMA,
and DMA. Under our analytical conditions,
we could not differentiate the trivalent forms
from the pentavalent forms of As.
Creatinine in urine. Urinary creatinine
was measured by Jaffe reaction with a com-
mercial kit (Jiancheng Biological Institute of
Nanjing, Nanjing, China). Concentrations of
As species and TAs were normalized to creati-
nine concentrations to correct for urine dilu-
tion (Valenzuela et al. 2005).
Statistical analysis. Data analysis was car-
ried out using SPSS software (version 11.5,
SPSS Inc., Chicago, IL, USA). The concen-
trations of As species, as well as PMI and
SMI, were first log-transformed. Analysis of
log-transformed data was performed using
one-way analysis of variance (ANOVA) and
the Student-Newman-Keuls (SNK) post hoc
test. We used the paired t-test to compare
child–mother differences. All values were
transformed back to the arithmetic scale for
reporting purposes.
Results
Distribution of urinary As metabolites between
children and adults. Both children and adults
had increased concentrations of each As
metabolite and the TAs, as the concentration of
iAs in drinking water increased from 20 µg/L
(control) to 90 and 160 µg/L (Table 1). The
urinary TAs of the 90- and 160-µg/L–exposed
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Table 1. Concentrations and percentages of As species in urine of children and adults.
160-µg/L–exposed group  90-µg/L–exposed group Control group
GM (95% CI) GM (95% CI) GM (95% CI)
Children Adults Children Adults Children Adults
n 44 56 47 50 16 20
Age, years 9.8 (9.0–10.6) 35.4 (32.6–38.1) 10.2 (9.3–11.1) 35.6 (32.5–38.6) 8.0 (6.4–8.9) 35 (31.1–38.1)
iAs (µg/g Cr) 82.4a,c,e (63.9–106.2) 101.85b,d(76.2–124.7) 48.7a,d(39.2–60.5) 39.4b (31.4–49.6) 1.0b (0.7–1.7) 0.4 (0.3–0.5)
MMA (µg/g Cr) 70.8a,c,e (57.4–87.3) 94.1b,d (71.16–24.7) 41.1a,d(34.7–48.6) 39.4b (32.8–47.4) 2.9b (2.3–3.9) 0.8 (0.6–1.1)
DMA (µg/g Cr) 408.8a,c,e (329.6–507.0) 423.2b,d (325.8–549.7) 206.1a,d (172.4–246.3) 163.5b (137.5–194.3) 29.3b (22.0–39.0) 7.7 (5.4–11.1)
TAs (µg/g Cr) 573.5a,c,e (464.8–707.5) 631.7b,d (485.6–821.7) 304.8a,d (257.4–361.1) 248.7b (208.8–296.3) 34.5b (26.5–45.0) 9.1 (6.5–12.7)
Percent iAs 12.7a,c(10.9–14.6) 14.4b (12.8–16.4) 16.0a (14.1–18.3) 15.8b (14.1–17.7) 2.8 (1.8–4.6) 4.16 (3.2–5.4)
Percent MMA 11.7a,c,e (10.8–12.6) 14.2b (13.1–15.3) 13.5a,d(12.4–14.6) 15.8b (14.6–17.0) 8.2 (7.0–9.6) 8.9 (7.0–11.2)
Percent DMA 73.3a,c,e (71.1–75.6) 68.9b (66.9–71.0) 67.6a,d(64.5–70.7) 65.8b (63.1–68.6) 84.6 (78.6–91.0) 85.0 (82.6–87.5)
Abbreviations: CI, conﬁdence interval; Cr, creatinine; GM, geometric mean.
ap < 0.05, compared with children in 20-µg/L–exposed group. bp < 0.05, compared with adults in 20-µg/L–exposed group. cp < 0.05, compared with children in 90-µg/L–exposed group. 
dp < 0.05, compared with adults in 90-µg/L–exposed group. ep < 0.05, compared with adults in 160-µg/L–exposed group.groups were, respectively, 7.8 and 15.6 times
that of the 20-µg/L–exposed group in children
and 26.3 and 68.4 times that in adults (p <
0.05; Table 1). In addition, urinary TAs of chil-
dren and adults in the 160-µg/L–exposed group
were, respectively, 1.88 and 2.54 times that in
the 90-µg/L–exposed group (p < 0.05; Table 1). 
Concentrations of all As metabolites were
higher in children than in adults in the
20-µg/L–exposed control group and in the
90-µg/L–exposed group (p < 0.05). However,
concentrations of all As metabolites were
lower in children than in adults in the
160-µg/L–exposed group (p < 0.05). In the
160-µg/L–exposed group, five adults had
extremely high concentrations of all urinary
As metabolites, about 5–10 times the average,
for reasons that we do not yet understand. If
we exclude the five adults, the geometric
means (GMs) for iAs, MMA, DMA, and TAs
(n = 51) would be lower—75, 71, 332, and
494 µg/g creatinine, respectively. GMs would
also be lower than those of the children in the
same group but without statistical signifi-
cance. In the 11 child–mother pairs also from
the 160-µg/L–exposed group, concentrations
of all As metabolites were higher for children
than for mothers (p < 0.01 except for MMA;
Table 2).
The distribution of As metabolites among
children and adults in the two exposed groups
followed the same trend compared with the
control group, with a decrease of percent
DMA and an increase of percent iAs and
MMA. Between the two exposed groups, per-
cent iAs and MMA were decreased, whereas
percent DMA was increased in children in the
160-µg/L–exposed group compared with the
90-µg/L–exposed group.
When exposed to the same concentration
of iAs in drinking water, children generally had
a higher percent DMA and a lower percent
MMA than adults in the two exposed groups,
which is consistent with the 11 child–mother
pairs in the 160-µg/L–exposed group (Table 2).
Distribution of urinary As metabolites
between male and female. For the 90- and
160-µg/L–exposed groups, there were no sig-
niﬁcant differences in concentrations or per-
centages of any of the As metabolites between
the male and female participants when they
were exposed to the same concentration of iAs
in drinking water (Table 3).
PMI and SMI. To facilitate the compari-
son of As metabolism between children and
adults, we also calculated PMI [(MMA +
DMA)/TAs] and SMI [DMA/(MMA +
DMA)]. Both PMI and SMI values in adults
and children signiﬁcantly decreased in the 90-
and 160-µg/L–exposed groups compared with
the control group, but the decrease in SMI
values occurred more in children than in
adults (Figure 1A, B). In the control group,
we found no significant differences in PMI
and SMI values between children and adults
(Figure 1B). However, for both the 90- and
160-µg/L–exposed groups, SMI values
(Figure 1B) were signiﬁcantly higher in chil-
dren than in adults (p < 0.05). SMI values
were also signiﬁcantly higher in children in the
160-µg/L–exposed group than that in children
in the 90-µg/L–exposed group (p < 0.05),
whereas the difference in adults was not as
large (Figure 1B). The slightly higher PMI val-
ues in children in the 160-µg/L–exposed
group (Figure 1A) were not signiﬁcantly dif-
ferent from that of adults in the same group.
These results suggest that children’s secondary
methylation ability is greater and more sensi-
tive to As exposure than adults. 
Children’s SMI values were higher than
those of their mothers in the 11 child–mother
pairs of in the 160-µg/L–exposed group
(Table 4), which is consistent with the ﬁnd-
ings from the child–adult comparison.
However, this difference was not significant
because of the small sample size (Table 4).
We did find an encouraging correlation of
SMI values between children and their moth-
ers (r = 0.655; p < 0.05). PMI values of chil-
dren and mothers were comparable, although
again without statistical significance, and
there was no correlation between PMI values
of children and their mothers (Table 4). 
Discussion
Age differences in As excretion and metabo-
lism. Higher levels of urinary As metabolites
in children than in adults from both the
90-µg/L–exposed and control groups suggest
that children’s ability to metabolize and
excrete iAs was greater than in adults when
exposed to the same concentrations of As
(Table 1). Children’s absolute excretion of As
in urine was less than that of adults in the
160-µg/L–exposed group when five adults
with high levels of urinary As were included
in the comparison. However, when adjusted
for body weight, the concentration of urinary
As species excreted in children was 1.5–1.9
times that of adults. After we excluded the
five adults with unusually high levels of uri-
nary As species and adjusted for body weight,
excretion in children increased 2.2–2.8 times
that in adults. These results indicate that
adults might accumulate more As in their
bodies than children do, based on the
assumption that children and adults consume
the same amount of As. A consistent feature
of our data is that the percent DMA and SMI
values in children in the two exposed groups
were higher, whereas the percent MMA was
lower than that in adults, suggesting that the
second methylation step is higher in children,
whereas the primary methylation step is not.
The percent of urinary As species and the
PMI and SMI values in children and adults in
the control group were similar, which sug-
gests that when the level of As in drinking
water was low, methylation ability in both
were comparable. Previous studies also found
total urinary As excretion adjusted for body
weight and the secondary methylation ability
of iAs were higher in children than in adults
(Chowdhury et al. 2003; Chung et al. 2002).
We do not know whether the better sec-
ondary methylation ability of children can
explain why they appear to be less affected
clinically by As exposure than adults exposed
to the same concentration of As in drinking
water (Chowdhury et al. 2003). However,
this would be consistent with previous find-
ings that the more cytotoxic MMAIII
decreased when the level of DMA increased,
as would be expected in the As metabolism
pathway (Cullen et al. 1984; Styblo et al.
2002; Vahter 2002). That MMA is a a more
toxic As metabolite than DMA is supported
by the fact that higher levels and greater pro-
portions of MMA have been found in indi-
viduals with arsenicosis than those in the
control group who had no symptoms but
who had been exposed to the same concentra-
tion of As (Calderon et al. 1999; Valenzuela
et al. 2005). 
In children, the secondary methylation
ability was not only greater but also more sen-
sitive to changes in the concentrations of As
to which they were exposed. In exposed
groups, both children and adults had lower As
methylation ability, as indicated by much
lower PMI and SMI values compared with
the control group (Figures 1A, B). Del Razo
et al. (1997) in a study of 35 individuals from
Santa Ana, Mexico, where drinking water had
Sun et al.
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Table 2. Concentrations and percentages of urinary As species for 11 child–mother pairs in the 160 µg/L-exposed group. 
iAs MMA DMA TAs  iAs MMA DMA
[µg/g Cr (95% CI)] [µg/g Cr (95% CI)] [µg/g Cr (95% CI)] [µg/g Cr (95% CI)] [% (95%CI]  [% (95%CI]  [% (95%CI] 
Mothers (GM) 30.8 (23.8–39.8) 34.9 (27.4–44.5) 172.8 (138.4–215.7) 241.0 (194.6–298.4) 12.8 (11.0–14.8) 14.5 (12.4–17.0) 71.7 (68.9–74.6)
Children (GM) 61.5 (45.6–82.9) 56.1 (38.9–80.8) 363.8 (300.4–440.4) 487.3 (391.9–606.1) 12.6 (11.2–14.2) 11.5 (9.2–14.4) 74.6 (71.4–78.0)
p-Valuea 0.002 0.060 0.001 0.001 0.848 0.038 0.017
Abbreviations: CI, conﬁdence interval; Cr, creatinine; GM, geometric mean.
aDifferences between child–mother urinary iAs, MMA, DMA, and TAs were obtained by paired t-test.an As concentration of 415 µg/L, observed
that exposure to high levels of As could
decrease the body’s ability to methylate As.
However, a subtle increase of percent DMA
(Table 1) and SMI values (Figure 1B) with a
decrease in percent iAs and MMA (Table 1),
which is significant for children, were
observed in the 160-µg/L–exposed group
compared with the 90-µg/L–exposed group.
This observation indicates the induction of As
methylation with increasing iAs exposure in
children, and is consistent with the study of
Concha et al. (1998). Although additional
studies are needed to conﬁrm this ﬁnding, the
implication is that increasing iAs exposure
does not always decrease children’s As methy-
lation ability, rather it may induce As methy-
lation ability within a certain range of iAs
exposure concentrations. 
Gender and As metabolism. Comparison
of urinary As between male and female partic-
ipants indicates that the concentrations and
distribution of As species do not vary by gen-
der (Table 3). The primary and secondary
methylation abilities of As were not different
between men and women when they were
exposed to the same levels of As. In Taiwan a
study of 479 people exposed to As (700–930
µg/L) in drinking water from artesian wells
found that women had a greater ability to
methylate As than men (Tseng et al. 2005).
Methylation of As was more efficient in
women than in men in three populations
studied: Mexico (n = 292), China (n = 37),
and Chile (n = 21) (Loffredo et al. 2005). We
cannot explain the apparent lack of difference
in women and men in Inner Mongolia except
to note that our study groups were exposed to
lower concentrations of iAs. We cannot
exclude the possible contribution of genetic
differences in the study group. 
Genetics and As metabolism. The orders
of proportions of urinary As metabolites was
as follows: percent DMA > percent iAs > per-
cent MMA for both of the exposed groups,
and percent DMA >> percent MMA > per-
cent iAs for the control group. This difference
may be because of exposure to a measurable
concentration of As in drinking water. The
order of urinary As species concentrations in a
population (n = 35) exposed to 396–470 µg/L
iAs in drinking water from a town in Mexico
was also percent DMA > percent iAs > per-
cent MMA (Del Razo et al. 1997). Similar to
most population groups studied to date, our
two exposed groups have on average 10–30%
iAs, 10–20% MMA, and 60–70% DMA in
urine (Vahter 2000), but there was a consid-
erable interindividual variation in the propor-
tions of urinary As metabolite. 
Could this variation be attributed to the
genetic polymorphisms in As methyltrans-
ferase or MMAV reductase (Concha et al.
2002; Karagas et al. 2004; Thomas et al.
2004)? Based on the variability of the urinary
As metabolic profile in humans (Loffredo
et al. 2003; Meza et al. 2004; Vahter 2000)
and the differences in interspecies and
intraspecies in animal models (Styblo et al.
1999; Thomas et al. 2001), genetic determi-
nants are hypothesized to play an important
role in As metabolism. A stronger correlation
in As methylation-related phenotypes found
among siblings than among genetically unre-
lated individuals is consistent with this
hypothesis (Chung et al. 2002). If a familial
aggregation of As methylation ability were to
be found, it would suggest that genetic factors
could underlie interindividual variation in
As metabolism. 
We noted a correlation of SMI values in
the 11 pairs of children and their mothers
that is consistent with a familial aggregation
of As metabolic profile. Unfortunately, our
small sample size makes this observation spec-
ulative until conﬁrmed by a follow-up study
of a larger sample size, which is currently
being conducted. Similar differences in As
metabolite concentrations and distribution of
child–mother pair and child–adult, however,
suggest that this finding is more systematic
than random. 
Arsenicosis and exposure. Our study did not
identify a single individual with arsenicosis even
when the iAs exposure concentration was 160
µg/L, more than 3 times the 50-µg/L As con-
centration permitted by the Standards of
Drinking Water Quality in China (Ministry of
Health 2006). We suspect that this may be due
to relatively short exposure time of 8–9 years.
In China, individuals with arsenicosis have usu-
ally been exposed for more than 20 years (Liu
et al. 2001), although we cannot rule out that
better nutrition as a result of improved local
economic conditions may play a role (Lammon
and Hood 2004; Steinmaus et al. 2005). 
Limitation. Urinary As is recognized as a
reliable indicator of recent exposure to iAs in
drinking water and is often used as the bio-
marker of As exposure (Calderon et al. 1999;
Yamauchi and Fowler 1994). The concentra-
tions of urinary As species in our study popu-
lation increased with As exposure, reflecting
iAs concentrations in the drinking water and
thus can be used as a biomarker. Seafood is
rare in the diet of the study population
because of the poor economic conditions and
the long distances of the villages from sea,
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Table 3. Concentrations and percentages (95% CI) of As species in urine for male and female.
160-µg/L-exposed group 90-µg/L-exposed group
Male Female Male Female
n 17 39 11 39
Age, years 30.1 (25.3–35.0) 37.7 (34.6–40.8) 35.0 (22.5–47.5) 31.4 (38.1–44.7)
iAs (µg/g Cr) 91.81 (56.80–148.40) 106.41 (74.13–183.93) 42.46 (27.54–65.47) 38.64 (29.52–50.58)
MMA (µg/g Cr) 86.73 (51.76–145.32) 97.57 (69.51–163.06) 41.71 (28.17–61.77) 38.80 (31.45–47.87)
DMA (µg/g Cr) 349.13 (213.72–570.35) 460.22 (337.88–734.91) 153.91 (95.17–248.90) 166.29 (139.01–198.93)
TAs (µg/g Cr) 537.27 (331.93–869.66) 677.88 (494.60–1092.75) 242.72 (155.00–380.07) 250.42 (207.28–302.55)
Percent iAs 15.92 (12.82–19.77) 13.84 (11.89–16.10) 17.25 (13.78–21.60) 15.40 (13.46–17.63)
Percent MMA 15.64 (14.18–17.25) 13.57 (12.31–14.97) 17.21 (14.52–20.38) 15.43 (14.18–16.79)
Percent DMA 66.30 (62.98–69.78) 70.10 (67.63–72.67) 63.50 (59.79–67.45) 66.43 (63.18–69.84)
Abbreviations: CI, conﬁdence interval; Cr, creatinine; GM, geometric mean.
Table 4. Comparison of PMI and SMI and correlation analysis (95% CI) of methylation indices in 11 child-
mother pairs. 
Mother Child  p-Value from  Correlation
GM (95% CI) GM (95% CI) paired t-testa r p-Valueb
PMI 0.867 (0.849–0.887) 0.871 (0.854–0.888) 0.772 0.328 0.325
SMI  0.826 (0.799–0.855) 0.857 (0.822–0.893) 0.050 0.655 0.029
Abbreviations: CI, conﬁdence interval; Cr, creatinine; GM, geometric mean.
aSigniﬁcant difference in PMI or SMI between children and mothers. bSigniﬁcance of correlation in PMI or SMI between
children and mothers.
Figure 1. (A) Comparison of PMI in children and adults exposed to different levels of As in drinking water.
Data are shown as geometric mean. (B) Comparison of SMI in children and adults exposed to different
levels of As. Data are shown as geometric mean. 
Statistical signiﬁcance: *p < 0.05, compared with children’s control group; #p < 0.05, compared with adult control group; 
†p < 0.05, compared with children in 160-µg/L–exposed group; ‡p < 0.05, compared with children in 90-µg/L–exposed group.
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thus we did not include this in our study.
The unstable nature of trivalent forms of
arsenicals (Aposhian et al. 2000; Del Razo
et al. 2001; Gong et al. 2001; Le et al. 2000),
especially MMAIII, prevented us from evalu-
ating the full spectrum of urinary As specia-
tion. Our findings imply that children may
beneﬁt from having better secondary methy-
lation than adults. Improved ability to quan-
tify the unstable trivalent forms of As may
hold the key in explaining the differences in
SMI values between children and adults, as
well as in people exposed to different levels of
As. The correlation found in the methylation
ability of child–mother pairs is interesting, but
larger sample sizes and further investigation
are needed.
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